TCL Archive New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics December 10, 1999
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive Conversation with The Cancer Letter: Is Republican Control Better Than Two-Party Stalemate? December 19, 2014
TCL Archive In Brief: Waldmann, Fisher Win Top Miken Prizes Of $250,000 Each, Six Others Get $50,000 November 10, 1989
TCL Archive New Grant Concepts Totaling $3 million a Year Approved, With New Contract, Two Recompetitions July 10, 1987
